Davidson Ebru bought KZIA
January 8, 2026 · Form 4 insider transaction
Davidson Ebru bought 100,000 shares of Kazia Therapeutics Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 181 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderDavidson Ebru
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2026
Filing dateJuly 8, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a board-approved award of 100,000 options over ADSs, approved by the Remuneration Committee on January 8, 2026, at an exercise price of $9.10 per ADS. The exercise price for Australian resident participants reflects Australian tax considerations applicable to grants under the Issuer's employee share plan. The options vest on January 8, 2027. The options were granted for no consideration and expire on January 8, 2029.